Propiedad y actividad de insiders de Abeona Therapeutics Inc. (ABEO): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $5.37 |
| Capitalización | $306M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $69.1M | $137.8M | $18.8M | $129.3M | $12.6M | $32.9M | $14.2M | $14.5M | $23.4M | $78.4M |
| Inversiones a Corto | 0 | 0 | $66.2M | 0 | $82.4M | $12.1M | $37.9M | $37.8M | $74.4M | $113.0M |
| Cuentas por Cobrar | $124000 | $107000 | $81000 | 0 | 0 | $3.0M | $188000 | $2.4M | $1.7M | $6.7M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $5.5M |
| Activos Corrientes | $69.4M | $140.6M | $88.9M | $132.4M | $97.7M | $56.3M | $53.1M | $55.7M | $100.9M | $204.9M |
| Inmovilizado Material | $721000 | $1.4M | $9.4M | $21.2M | $18.4M | $21.7M | $11.1M | $8.0M | $8.0M | $13.9M |
| Fondo de Comercio | $32.5M | $32.5M | $32.5M | $32.5M | $32.5M | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $8.4M | $4.0M | $43.0M | $36.2M | $1.5M | $1.4M | 0 | 0 | 0 | 0 |
| Activos Totales | $111.1M | $178.8M | $174.4M | $223.4M | $151.2M | $79.6M | $64.2M | $64.0M | $108.9M | $219.6M |
| Cuentas por Pagar | $3.7M | $1.9M | $6.1M | $3.8M | $4.7M | $4.3M | $1.8M | $1.9M | $3.4M | $7.9M |
| Deuda a Corto | 0 | 0 | $10.0M | 0 | $330000 | 0 | 0 | 0 | $5.9M | $12.2M |
| Pasivos Corrientes | $8.3M | $5.6M | $20.4M | $38.7M | $42.0M | $16.6M | $7.8M | $13.4M | $16.6M | $29.6M |
| Deuda a Largo | 0 | 0 | $20.0M | 0 | $1.4M | 0 | 0 | 0 | $13.0M | $7.8M |
| Pasivos Totales | $12.0M | $8.7M | $40.4M | $45.0M | $48.6M | $37.2M | $37.5M | $49.2M | $64.9M | $60.4M |
| Reservas | -$332.5M | -$359.8M | -$410.2M | -$486.5M | -$570.7M | -$655.6M | -$695.3M | -$749.5M | -$813.3M | -$742.1M |
| Patrimonio Neto | $99.1M | $170.1M | $134.0M | $178.4M | $102.6M | $42.4M | $26.8M | $14.8M | $44.0M | $159.2M |
| Deuda Total | 0 | 0 | $30.0M | $8.0M | $8.7M | $9.4M | $7.6M | $5.4M | $23.0M | $25.0M |
| Deuda Neta | -$69.1M | -$137.8M | -$55.0M | -$121.3M | -$86.3M | -$35.6M | -$44.5M | -$46.8M | -$74.7M | -$166.4M |
| Capital Circulante | $61.1M | $135.0M | $68.5M | $93.7M | $55.8M | $39.7M | $45.3M | $42.3M | $84.3M | $175.3M |
Salud financiera
| Deuda / Patrimonio | 0.16 |
| Ratio corriente | 6.63 |
Rentabilidad
| Rentabilidad sobre capital | -41.69% |
| Rentabilidad sobre capital invertido | -39.66% |
| Rentabilidad sobre activos | -35.03% |
| Margen bruto | 56.63% |
| Margen operativo | -327.64% |
| Margen neto | -246.42% |
Empresas relacionadas: ARCT · ASMB · ELDN · FHTX · HUMA · PBYI · SGMT
Explorar sector: Healthcare · Biotechnology
Más secciones de ABEO: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones